Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Boston Commerce Limited (BOSTON) Share Price & Fundamentals

Company Overview

Founded Year

1995

Listed Year

-

Headquarter

Gujarat, India

MD/CEO

Ghanshyam Dhananjay Gavali - Managing Director; Yash Arun Chaudhary - Director; experienced leadership driving company turnaround.

Website

https://bostonbio.in

Company Facts

What we do

Boston Commerce Limited, formerly Boston Bio Systems Limited, specializes in trading medical equipment, testing kits, and jobworking for herbal and health-related products with customized manufacturing and private labeling.

Founded in

1,995

Market share

-

Problem solved

Addresses demand for high-quality herbal supplements and medical testing products, aiding businesses in product development and manufacturing for health and wellness.

Top clients or who we serve

B2B clients including herbal product businesses and healthcare providers requiring medical equipment and custom manufacturing services.

Key management

Ghanshyam Dhananjay Gavali - Managing Director; Yash Arun Chaudhary - Director; experienced leadership driving company turnaround.

Our journey and innovations

Transitioned from share broking to healthcare and herbal products; regained listing status at BSE; focus on growth in herbal and medical product sectors.

Where we operate

Primarily India; poised for market expansion following trading reinstatement on BSE.

Top products or what we offer

Medical testing kits, equipment, custom buffers, herbal supplements manufacturing, and private label wellness products.

Top brands

-

Raw materials needed

Herbal raw materials, medical components, and formulation ingredients for product manufacturing.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue largely cyclical with project-based custom manufacturing and trading sales.

Our industry position

Emerging player in herbal product manufacturing and medical equipment trading, focusing on customized solutions.

Financial highlights

FY2024-25 revenue ₹19.25 lakhs; net loss ₹54.73 lakhs due to scale-up and restructuring efforts; focused on recovery and growth.

Geographical revenue split

-

Order book

-

Whats driving growth

Increasing demand for herbal wellness products and medical testing solutions; operational improvements post trading reinstatement.

Our future plans

Enhance revenue through strategic growth, improve production capacity, and expand market presence in healthcare and wellness sectors.

Our green promise

-

Our people and values

Small dedicated workforce with emphasis on ethics and compliance; supportive work culture and governance practices.

Key challenges ahead

Financial losses, market competition, regulatory compliance, and need for scaling operations effectively.

Interesting facts

Reinstated trading on BSE after suspension by overhauling governance and operational controls.

Risks and strategy

Mitigating financial and regulatory risks via governance reforms and focusing on niche herbal and medical product markets.

Market Footprint

Top Clients

Top Clients

B2B clients including herbal product businesses and healthcare providers requiring medical equipment and custom manufacturing services.

Top Products

Top Products

Medical testing kits, equipment, custom buffers, herbal supplements manufacturing, and private label wellness products.

Price Movement & Share Holding

Today's High/Low

10.7811.22

52 Week High/Low

4.0111.22
Past Returns

1 week

9.56%

1 month

25.57%

3 month

100%

1 year

104.46%

3 year

104.46%

5 year

104.46%

Share Holding

Promoters

2.14%

FII

0%

DII

2.13%

Retail

88.9%

Others

6.83%

Company Overview

Founded Year

1995

Listed Year

-

Headquarter

Gujarat, India

MD/CEO

Ghanshyam Dhananjay Gavali - Managing Director; Yash Arun Chaudhary - Director; experienced leadership driving company turnaround.

Website

https://bostonbio.in

Price Movement & Share Holding

Today's High/Low

10.7811.22

52 Week High/Low

4.0111.22

Past Returns

1 week

9.56%

1 month

25.57%

3 month

100%

1 year

104.46%

3 year

104.46%

5 year

104.46%

Share Holding

Promoters

2.14%

FII

0%

DII

2.13%

Retail

88.9%

Others

6.83%

Company Facts

What we do

Boston Commerce Limited, formerly Boston Bio Systems Limited, specializes in trading medical equipment, testing kits, and jobworking for herbal and health-related products with customized manufacturing and private labeling.

Founded in

1995

Problem solved

Addresses demand for high-quality herbal supplements and medical testing products, aiding businesses in product development and manufacturing for health and wellness.

Top clients or who we serve

B2B clients including herbal product businesses and healthcare providers requiring medical equipment and custom manufacturing services.

Key management

Ghanshyam Dhananjay Gavali - Managing Director; Yash Arun Chaudhary - Director; experienced leadership driving company turnaround.

Our journey and innovations

Transitioned from share broking to healthcare and herbal products; regained listing status at BSE; focus on growth in herbal and medical product sectors.

Where we operate

Primarily India; poised for market expansion following trading reinstatement on BSE.

Top products or what we offer

Medical testing kits, equipment, custom buffers, herbal supplements manufacturing, and private label wellness products.

Raw materials needed

Herbal raw materials, medical components, and formulation ingredients for product manufacturing.

Recurring vs cyclical contribution

Revenue largely cyclical with project-based custom manufacturing and trading sales.

Our industry position

Emerging player in herbal product manufacturing and medical equipment trading, focusing on customized solutions.

Financial highlights

FY2024-25 revenue ₹19.25 lakhs; net loss ₹54.73 lakhs due to scale-up and restructuring efforts; focused on recovery and growth.

Whats driving growth

Increasing demand for herbal wellness products and medical testing solutions; operational improvements post trading reinstatement.

Our future plans

Enhance revenue through strategic growth, improve production capacity, and expand market presence in healthcare and wellness sectors.

Our people and values

Small dedicated workforce with emphasis on ethics and compliance; supportive work culture and governance practices.

Key challenges ahead

Financial losses, market competition, regulatory compliance, and need for scaling operations effectively.

Interesting facts

Reinstated trading on BSE after suspension by overhauling governance and operational controls.

Risks and strategy

Mitigating financial and regulatory risks via governance reforms and focusing on niche herbal and medical product markets.

Market Footprint

Top Clients

Top Clients

B2B clients including herbal product businesses and healthcare providers requiring medical equipment and custom manufacturing services.

Top Products

Top Products

Medical testing kits, equipment, custom buffers, herbal supplements manufacturing, and private label wellness products.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions